$LABT SEC Filings

Filed On	Filing
29 Sep 2026	8-K: Submission of Matters to a Vote of Security Holders On September 22, 2026, Lakewood-Amedex Biotherapeutics Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). As of the record date of July 30, 2026, there were 2,369,688 shares of Common Stock outstand...
24 Sep 2026	EFFECT
18 Sep 2026	REGISTRATION STATEMENT
24 Aug 2026	DRS
17 Aug 2026	PROSPECTUS SUPPLEMENT
14 Aug 2026	SCHEDULE 13G
14 Aug 2026	QUARTERLY REPORT
10 Aug 2026	DEFINITIVE ADDITIONAL MATERIALS
10 Aug 2026	Proxy statement: annual meeting on September 22, 2026
06 Aug 2026	SCHEDULE 13G
30 Jul 2026	PRELIMINARY PROXY STATEMENT
15 Jul 2026	8-K: Regulation FD Disclosure
23 Jun 2026	SCHEDULE 13G
22 Jun 2026	PROSPECTUS SUPPLEMENT
22 Jun 2026	PROSPECTUS SUPPLEMENT
17 Jun 2026	8-K: Material Modification to Rights of Security Holders; Amendments to Articles/Bylaws; Change in Fiscal Year
26 May 2026	PROSPECTUS SUPPLEMENT
26 May 2026	PROSPECTUS SUPPLEMENT
22 May 2026	QUARTERLY REPORT
14 May 2026	PROSPECTUS

Comments